Pfizer-BioNTech COVID-19 vaccine: Authorization information

On this page

Market authorization with conditions

Health Canada authorized the Pfizer-BioNTech COVID-19 mRNA vaccine (Tozinameran or BNT162b2) for use for the COVID-19 pandemic. Authorization followed section 5 of the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

Due to the urgent public health needs relating to COVID-19, we can issue a market authorization with conditions to support early access to promising health products when the potential benefits outweigh the potential risks.

The approval of the vaccine is supported by evidence that it is safe, effective and of good quality. Find detailed technical information about the Pfizer-BioNTech COVID-19 vaccine, such as the product monograph and our regulatory decision summary, in the COVID-19 vaccines and treatments regulatory portal.

According to the terms and conditions that Health Canada placed on the authorization, the manufacturer (Pfizer Canada ULC and BioNTech Manufacturing GmbH) will submit to Health Canada:

Risk management plan

Companies are required to submit a risk management plan (RMP) to Health Canada when applying for any marketing authorization.

RMPs include information on:

Health Canada reviewed the RMP for the Pfizer-BioNTech COVID-19 vaccine and found it to be acceptable.

International considerations

In addition to working with the Public Health Agency of Canada and provinces and territories, Health Canada also exchanges information with our international regulatory counterparts on an ongoing basis. This collaboration helps to support the review process, pharmacovigilance and post-market safety monitoring activities.

We will continue to actively monitor and review all relevant data to determine whether changes to the market authorization of the Pfizer-BioNTech COVID-19 vaccine in Canada are required.

Related links

Did you find what you were looking for?

What was wrong?

(Don't include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Date modified: